Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation

REFERENCES

• Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and R. A. Phillips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256–3265.
   PubMedGoogle Scholar
• Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Chang, M. W., E. Barr, J. Seltzer, Y. Q. Jiang, G. J. Nabel, E. G. Nabel, M. S. Parmacek, and J. M. Leiden. 1995. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518–522.
   PubMed Web of Science ®Google Scholar
• Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549–4553.
   PubMed Web of Science ®Google Scholar
• Chow, K. N., P. Starostik, and D. C. Dean. 1996. The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol. Cell. Biol. 16:7173–7181.
   PubMedGoogle Scholar
• Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by sitespecific phosphorylation. Mol. Biol. Cell 8:287–301.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., T. Kowalik, and J. R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224.
   PubMed Web of Science ®Google Scholar
• Fattaey, A. R., E. Harlow, and K. Helin. 1993. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13:7267–7277.
   PubMed Web of Science ®Google Scholar
• Flemington, E. K., S. H. Speck, and W. G. Kaelin, Jr. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914–6918.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., N. P. Wang, Y. W. Qian, E. Y. Lee, and W. H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., and W. H. Lee. 1992. Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature 360:177–179.
   PubMedGoogle Scholar
• Hamel, P. A., B. L. Cohen, L. M. Sorce, B. L. Gallie, and R. A. Phillips. 1990. Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions. Mol. Cell. Biol. 10:6586–6595.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7:693–701.
   PubMedGoogle Scholar
• Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431–3438.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., R. A. Phillips, M. Muncaster, and B. L. Gallie. 1993. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 7:846–854.
   PubMed Web of Science ®Google Scholar
• Hensey, C. E., F. T. Hong, T. Durfee, Y. W. Qian, E. Y. Lee, and W. H. Lee. 1996. Identification of discrete structural domains in the retinoblastoma protein. Amino-terminal domain is required for its oligomerization. J. Biol. Chem. 269:1380–1387.
   Google Scholar
• Herrera, R. E., T. P. Mäkelä, and R. A. Weinberg. 1996. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7:1335–1342.
   PubMedGoogle Scholar
• Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Mäkelä, R. A. Weinberg, and T. Jacks. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402–2407.
   PubMedGoogle Scholar
• Hiebert, S. W. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384–3391.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hu, Q. J., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147–1155.
   PubMed Web of Science ®Google Scholar
• Huang, P. S., D. R. Patrick, G. Edwards, P. J. Goodhart, H. E. Huber, L. Miles, V. M. Garsky, A. Oliff, and D. C. Heimbrook. 1993. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol. 13:953–960.
   PubMedGoogle Scholar
• Huang, S., N. P. Wang, B. Y. Tseng, W. H. Lee, and E. H. Lee. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9:1815–1822.
   PubMed Web of Science ®Google Scholar
• Ikeda, M. A., and J. R. Nevins. 1993. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13:7029–7035.
   PubMedGoogle Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature 365:349–352.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761–3769.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, and S. Nishimura. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060–7069.
   PubMed Web of Science ®Google Scholar
• Knudsen, E. S., and J. Y. Wang. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271:8313–8320.
   PubMed Web of Science ®Google Scholar
• Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375:506–510.
   PubMed Web of Science ®Google Scholar
• Lam, E. W., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705–2713.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279–4290.
   PubMed Web of Science ®Google Scholar
• Lin, B. T., S. Gruenwald, A. O. Morla, W. H. Lee, and J. Y. Wang. 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10:857–864.
   PubMed Web of Science ®Google Scholar
• Lin, B. T., and J. Y. Wang. 1992. Cell cycle regulation of retinoblastoma protein phosphorylation. Ciba Found. Symp. 170:227–241.
   PubMedGoogle Scholar
• Ludlow, J. W., C. L. Glendening, D. M. Livingston, and J. A. DeCarprio. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367–372.
   PubMed Web of Science ®Google Scholar
• Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503–506.
   PubMed Web of Science ®Google Scholar
• Medema, R. H., R. E. Herrera, F. Lam, and R. A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289–6293.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Qian, Y., C. Luckey, L. Horton, M. Esser, and D. J. Templeton. 1992. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12:5363–5372.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953–964.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., D. M. Livingston, M. Ewen, W. R. Sellers, Z. Arany, and W. G. Kaelin, Jr. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15:742–755.
   PubMedGoogle Scholar
• Sellers, W. R., J. W. Rodgers, and W. G. Kaelin, Jr. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Slansky, J. E., and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208:1–30.
   PubMed Web of Science ®Google Scholar
• Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033–3037.
   PubMed Web of Science ®Google Scholar
• Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869–881.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y. 1997. Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev. 7:39–45.
   PubMedGoogle Scholar
• Wang, J. Y., E. S. Knudsen, and P. J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64:25–85.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1994. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   Google Scholar
• Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259–261.
   PubMed Web of Science ®Google Scholar
• Welch, P. J., and J. Y. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779–790.
   PubMed Web of Science ®Google Scholar
• Welch, P. J., and J. Y. Wang. 1995. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev. 9:31–46.
   PubMedGoogle Scholar
• Welch, P. J., and J. Y. Wang. 1995. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell. Biol. 15:5542–5551.
   PubMed Web of Science ®Google Scholar
• Whitaker, L. L., H. Su, and J. Y. J. Wang. Unpublished data.
   Google Scholar
• Xiao, Z. X., J. Chen, A. J. Levine, N. Modjtahedi, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694–698.
   PubMed Web of Science ®Google Scholar
• Zarkowska, T., and S. Mittnacht. 1997. Differential phosphorylation of the retinoblastoma protein by G(1)/S cyclin-dependent kinases. J. Biol. Chem. 272:12738–12746.
   PubMed Web of Science ®Google Scholar
• Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111–1125.
   PubMed Web of Science ®Google Scholar
• Zwicker, J., F. C. Lucibello, L. A. Wolfraim, C. Gross, M. Truss, K. Engeland, and R. Müller. 1995. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:4514–4522.
   PubMed Web of Science ®Google Scholar
• Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Müller. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595–1597.
   PubMed Web of Science ®Google Scholar